BACKGROUND: The discovery of genetic mutations in children with inherited syndromes of intrahepatic cholestasis allows for diagnostic specificity despite similar clinical phenotypes. Here, we aimed to determine whether mutation screening of target genes could assign a molecular diagnosis in children with idiopathic cholestasis. PATIENTS AND METHODS: DNA samples were obtained from 51 subjects with cholestasis of undefined etiology and surveyed for mutations in the genes SERPINA1, JAG1, ATP8B1, ABCB11, and ABCB4 by a high-throughput gene chip. Then, the sequence readouts for all 5 genes were analyzed for mutations and correlated with clinical phenotypes. Healthy subjects served as controls. RESULTS: Sequence analysis of the genes identified 14 (or 27%) subjects with missense, nonsense, deletion, and splice site variants associated with disease phenotypes based on the type of mutation and/or biallelic involvement in the JAG1, ATP8B1, ABCB11, or ABCB4 genes. These patients had no syndromic features and could not be differentiated by biochemical markers or histopathology. Among the remaining subjects, 10 (or ∼20%) had sequence variants in ATP8B1 or ABCB11 that involved only 1 allele, 8 had variants not likely to be associated with disease phenotypes, and 19 had no variants that changed amino acid composition. CONCLUSIONS: Gene sequence analysis assigned a molecular diagnosis in 27% of subjects with idiopathic cholestasis based on the presence of variants likely to cause disease phenotypes.
BACKGROUND: The discovery of genetic mutations in children with inherited syndromes of intrahepatic cholestasis allows for diagnostic specificity despite similar clinical phenotypes. Here, we aimed to determine whether mutation screening of target genes could assign a molecular diagnosis in children with idiopathic cholestasis. PATIENTS AND METHODS: DNA samples were obtained from 51 subjects with cholestasis of undefined etiology and surveyed for mutations in the genes SERPINA1, JAG1, ATP8B1, ABCB11, and ABCB4 by a high-throughput gene chip. Then, the sequence readouts for all 5 genes were analyzed for mutations and correlated with clinical phenotypes. Healthy subjects served as controls. RESULTS: Sequence analysis of the genes identified 14 (or 27%) subjects with missense, nonsense, deletion, and splice site variants associated with disease phenotypes based on the type of mutation and/or biallelic involvement in the JAG1, ATP8B1, ABCB11, or ABCB4 genes. These patients had no syndromic features and could not be differentiated by biochemical markers or histopathology. Among the remaining subjects, 10 (or ∼20%) had sequence variants in ATP8B1 or ABCB11 that involved only 1 allele, 8 had variants not likely to be associated with disease phenotypes, and 19 had no variants that changed amino acid composition. CONCLUSIONS: Gene sequence analysis assigned a molecular diagnosis in 27% of subjects with idiopathic cholestasis based on the presence of variants likely to cause disease phenotypes.
Authors: Janneke M Stapelbroek; Karel J van Erpecum; Leo W J Klomp; Niels G Venneman; Thijs P Schwartz; Gerard P van Berge Henegouwen; John Devlin; Carin M J van Nieuwkerk; A S Knisely; Roderick H J Houwen Journal: Hepatology Date: 2006-01 Impact factor: 17.425
Authors: A S Knisely; Sandra S Strautnieks; Yvonne Meier; Bruno Stieger; Jane A Byrne; Bernard C Portmann; Laura N Bull; Ludmila Pawlikowska; Banu Bilezikçi; Figen Ozçay; Aranka László; László Tiszlavicz; Lynette Moore; Jeremy Raftos; Henrik Arnell; Björn Fischler; Antal Németh; Nikos Papadogiannakis; Joanna Cielecka-Kuszyk; Irena Jankowska; Joanna Pawłowska; Hector Melín-Aldana; Karan M Emerick; Peter F Whitington; Giorgina Mieli-Vergani; Richard J Thompson Journal: Hepatology Date: 2006-08 Impact factor: 17.425
Authors: R Müllenbach; A Bennett; N Tetlow; N Patel; G Hamilton; F Cheng; J Chambers; R Howard; S D Taylor-Robinson; C Williamson Journal: Gut Date: 2005-06 Impact factor: 23.059
Authors: D M Warthen; E C Moore; B M Kamath; J J D Morrissette; P A Sanchez-Lara; P Sanchez; D A Piccoli; I D Krantz; N B Spinner Journal: Hum Mutat Date: 2006-05 Impact factor: 4.878
Authors: Thomas Lang; Michael Haberl; Diana Jung; Anja Drescher; Robert Schlagenhaufer; Andrea Keil; Esther Mornhinweg; Bruno Stieger; Gerd A Kullak-Ublick; Reinhold Kerb Journal: Drug Metab Dispos Date: 2006-06-08 Impact factor: 3.922
Authors: L N Bull; M J van Eijk; L Pawlikowska; J A DeYoung; J A Juijn; M Liao; L W Klomp; N Lomri; R Berger; B F Scharschmidt; A S Knisely; R H Houwen; N B Freimer Journal: Nat Genet Date: 1998-03 Impact factor: 38.330
Authors: Kimberley Evason; Kevin E Bove; Milton J Finegold; A S Knisely; Sue Rhee; Philip Rosenthal; Alexander G Miethke; Saul J Karpen; Linda D Ferrell; Grace E Kim Journal: Am J Surg Pathol Date: 2011-05 Impact factor: 6.394
Authors: Stephanie Barbara Schatz; Christoph Jüngst; Verena Keitel-Anselmo; Ralf Kubitz; Christina Becker; Patrick Gerner; Eva-Doreen Pfister; Imeke Goldschmidt; Norman Junge; Daniel Wenning; Stephan Gehring; Stefan Arens; Dirk Bretschneider; Dirk Grothues; Guido Engelmann; Frank Lammert; Ulrich Baumann Journal: Hepatol Commun Date: 2018-03-22
Authors: Paula M Hertel; Kieran Hawthorne; Sehee Kim; Milton J Finegold; Benjamin L Shneider; James E Squires; Nitika A Gupta; Laura N Bull; Karen F Murray; Nanda Kerkar; Vicky L Ng; Jean P Molleston; Jorge A Bezerra; Kathleen M Loomes; Sarah A Taylor; Kathleen B Schwarz; Yumirle P Turmelle; Philip Rosenthal; John C Magee; Ronald J Sokol Journal: J Pediatr Gastroenterol Nutr Date: 2021-10-01 Impact factor: 3.288